
Medical Device and Pharmaceutical R&D Manufacturer
Weigao Co., Ltd.(01066) up over 3%; as of press time, it rose 3.04% to HK$3.39, with a trading volume of HK$47.1494 million.
In terms of news flow, on June 5, Weigao Group Co., Ltd. announced that its board of directors had received notification from the company’s controlling shareholder, WEGO, stating that between May 15, 2026, and the date of this announcement, WEGO purchased a total of 11.4008 million H shares of the company in the open market using its own funds, representing approximately 0.25% of the total issued H shares and approximately 0.25% of the total issued shares of the company as of the date of this announcement. From May 13, 2026, to the date of this announcement, WEGO has purchased a total of 14.9536 million H shares of the company in the open market, representing approximately 0.33% of the total issued H shares and approximately 0.33% of the total issued shares of the company as of the date of this announcement, with a total consideration of approximately HK$50.9 million.
Following this increase in shareholding, as of the date of this announcement, WEGO Group holds a total of 2.115 billion H shares in the Company, representing approximately 46.76% of the total issued H shares and 46.27% of the total issued share capital of the Company. The aforementioned increase in shareholding fully demonstrates WEGO Group’s firm confidence in the long-term development prospects and intrinsic value of the Group, as well as its full support for the Group’s continued steady development.